Gemtuzumab
Modify Date: 2024-01-03 11:55:34
Gemtuzumab structure
|
Common Name | Gemtuzumab | ||
|---|---|---|---|---|
| CAS Number | 220578-59-6 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GemtuzumabGemtuzumab (Gemtuzumab ozogamicin) is an antibody-drug conjugate (ADC) consisting of a monoclonal antibody targeting CD33 linked to a cytotoxic derivative of Calicheamicin. Gemtuzumab can be used for the research of acute myeloid leukemia[1]. |
| Name | Gemtuzumab |
|---|
| Description | Gemtuzumab (Gemtuzumab ozogamicin) is an antibody-drug conjugate (ADC) consisting of a monoclonal antibody targeting CD33 linked to a cytotoxic derivative of Calicheamicin. Gemtuzumab can be used for the research of acute myeloid leukemia[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |